Zobrazeno 1 - 10 of 1 014 pro vyhledávání: '"Viladomiu, L."'
1
Akademický článek
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.
Autor: Riveiro-Barciela M; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; CIBERehd, Instituto Carlos III, Barcelona, Spain., Barreira-Díaz A; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Salcedo MT; Human Pathology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Callejo-Pérez A; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Muñoz-Couselo E; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Iranzo P; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Ortiz-Velez C; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Cedrés S; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Díaz-Mejía N; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Ruiz-Cobo JC; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Morales R; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Aguilar-Company J; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Zamora E; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Oliveira M; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Sanz-Martínez MT; Immunology Division, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Translational Immunology Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain., Viladomiu L; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Martínez-Gallo M; Immunology Division, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Translational Immunology Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain., Felip E; Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Buti M; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; CIBERehd, Instituto Carlos III, Barcelona, Spain.
Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Apr; Vol. 59 (7), pp. 865-876. Date of Electronic Publication: 2024 Feb 07.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Autor: Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Barreira-Díaz A; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain., Vidal-González J; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain., Muñoz-Couselo E; Oncology Department, Instituto de Oncología Vall d'Hebron (VHIO), Hospital Universitario Vall de Hebrón, Barcelona, Spain., Martínez-Valle F; Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Viladomiu L; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain., Mínguez B; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Ortiz-Velez C; Oncology Department, Instituto de Oncología Vall d'Hebron (VHIO), Hospital Universitario Vall de Hebrón, Barcelona, Spain., Castells L; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Esteban R; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Buti M; Liver Unit, Internal Medicine Department, Hospital Universitario Vall de Hebrón, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Aug; Vol. 40 (8), pp. 1906-1916. Date of Electronic Publication: 2020 Jun 03.
Zobrazit plný text záznamu
5
Environmental regulations in the hog farming sector: a comparison of Catalonia,Spain and Manitoba, Canada
Autor: Viladomiu, L., Soldevila-Lafon, V., Ramsey, D.
Publikováno v: Land Use Policy
Repositori Institucional de la Universitat Rovira i Virgili
Universitat Rovira i virgili (URV)
10.1016/j.landusepol.2012.10.020 This article examines the governance structures for managing the location and operation of Intensive Livestock Farming Operations (ILFOs). The article focuses on the hog sector and compares two very different jurisdic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::16234265b0026642d6e308dafdc51f3b
http://hdl.handle.net/20.500.11797/PC234
Zobrazit plný text záznamu
6
Akademický článek
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review.
Autor: Ruli Jr., Thomas M.1 (AUTHOR) edpollack@uabmc.edu, Pollack, Ethan D.1 (AUTHOR) alodh@uabmc.edu, Lodh, Atul1 (AUTHOR) christopherprice@uabmc.edu, Evers III, Charles D.1 (AUTHOR), Price, Christopher A.1 (AUTHOR), Shoreibah, Mohamed2 (AUTHOR) mshoreibah@uabmc.edu
Publikováno v: Cancers. Jun2024, Vol. 16 Issue 11, p2042. 21p.
Zobrazit plný text záznamu
7
Agri-environmental policies in Spain. Implication of natural parks for the rural labour market
Autor: Viladomiu, L.
Publikováno v: 1. Séminaire RUSSTIC
1. Séminaire RUSSTIC, Jan 1995, Dublin, Germany. 15 p
International audience; La première partie de l'article étudie l'évolution et la situation actuelle de la politique environnementale dans l'espace rural en Espagne en analysant les conflits entre conservation et développement rural. La deuxième
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1996f2f785b53eed8809bf5d0dd5d15f
https://hal.inrae.fr/hal-02845334
Zobrazit plný text záznamu
8
Akademický článek
High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping.
Autor: Rodriguez-Frias F; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain. Electronic address: frarodri@vhebron.net., Nieto-Aponte L; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain; Clinical Microbiology Department, HUVH, Barcelona, Spain., Gregori J; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Roche Diagnostics SL, Sant Cugat del Vall_es, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Garcia-Cehic D; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Casillas R; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain; Clinical Microbiology Department, HUVH, Barcelona, Spain., Tabernero D; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain., Homs M; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain., Blasi M; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain., Vila M; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain., Chen Q; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain., Vargas V; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Castells L; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Viladomiu L; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Genesca J; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Minguez B; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Augustin S; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Riveiro-Barciela M; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Carbonell J; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Perales C; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Soria ME; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Asensio M; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain., Llorens M; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain., Ordeig L; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain., Godoy C; Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain., Buti M; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Esteban R; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Pumarola T; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Clinical Microbiology Department, HUVH, Barcelona, Spain., Esteban JI; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain., Quer J; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Hepaticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain; Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain; Liver Unit, Malalties Hepatiques, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-HUVH), Barcelona, Spain. Electronic address: josep.quer@vhir.org.
Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2017 Oct; Vol. 23 (10), pp. 775.e1-775.e6. Date of Electronic Publication: 2017 Feb 10.
Zobrazit plný text záznamu
9
Akademický článek
Inferior Cava Vein Syndrome and Heart Compression Due to a Giant Liver Cyst.
Autor: Nicolau PB; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain., Lázaro JL; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain., Viladomiu L; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain., Casabiel XM; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain., Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v: The American journal of gastroenterology [Am J Gastroenterol] 2017 Jul; Vol. 112 (7), pp. 984.
Zobrazit plný text záznamu
10
Akademický článek
El papel y la contribución de los agentes de empleo y desarrollo local (AEDLs): análisis del caso gallego.
Autor: Octavio del Campo Villares, Manuel1 moctadcv@udc.es, Ferreiro Seoane, Francisco Jesús2 franciscojesus.ferreiro@usc.es, Miguéns Refojo, Vanessa3 vanessa.miguens@uam.es, Jardón Ferreiro, Eladio4 info@institutoimc.com
Publikováno v: Terra: Revista de Desarrollo Local. jul2024, Issue 14, p1-22. 22p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje